Discover innovative schizophrenia treatment options targeting cognitive symptoms for improved patient independence.
Explore the link between gut health and chronic kidney disease, revealing how bacteria impact kidney function.
Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.
Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.
Explore new findings on bladder cancer and inflammation's role in immune suppression. Discover insights to improve treatment.
Understand the impact of AI coding on scientific workflows and how it can make computational tools more accessible to researchers.
LabGenius Therapeutics will present preclinical data for LGTX-101, its AI-designed Nectin-4 x CD3 T-cell engager, at AACR 2026 in San Diego.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results